Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival and proliferation factors of normal and malignant plasma cells.
Klein B, Tarte K, Jourdan M, Mathouk K, Moreaux J, Jourdan E, Legouffe E, De Vos J, Rossi JF. Klein B, et al. Among authors: moreaux j. Int J Hematol. 2003 Aug;78(2):106-13. doi: 10.1007/BF02983377. Int J Hematol. 2003. PMID: 12953803 Free PMC article. Review.
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.
Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, Kaukel P, Pantesco V, De Vos J, Jourdan E, Jauch A, Legouffe E, Moos M, Fiol G, Goldschmidt H, Rossi JF, Hose D, Klein B. Moreaux J, et al. Blood. 2005 Aug 1;106(3):1021-30. doi: 10.1182/blood-2004-11-4512. Epub 2005 Apr 12. Blood. 2005. PMID: 15827134 Free PMC article.
Microarray-based understanding of normal and malignant plasma cells.
De Vos J, Hose D, Rème T, Tarte K, Moreaux J, Mahtouk K, Jourdan M, Goldschmidt H, Rossi JF, Cremer FW, Klein B. De Vos J, et al. Among authors: moreaux j. Immunol Rev. 2006 Apr;210:86-104. doi: 10.1111/j.0105-2896.2006.00362.x. Immunol Rev. 2006. PMID: 16623766 Free PMC article. Review.
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
Mahtouk K, Cremer FW, Rème T, Jourdan M, Baudard M, Moreaux J, Requirand G, Fiol G, De Vos J, Moos M, Quittet P, Goldschmidt H, Rossi JF, Hose D, Klein B. Mahtouk K, et al. Among authors: moreaux j. Oncogene. 2006 Nov 16;25(54):7180-91. doi: 10.1038/sj.onc.1209699. Epub 2006 May 29. Oncogene. 2006. PMID: 16732320 Free PMC article.
CD200 is a new prognostic factor in multiple myeloma.
Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E, Moine P, Bourin P, Moos M, Corre J, Möhler T, De Vos J, Rossi JF, Goldschmidt H, Klein B. Moreaux J, et al. Blood. 2006 Dec 15;108(13):4194-7. doi: 10.1182/blood-2006-06-029355. Epub 2006 Aug 31. Blood. 2006. PMID: 16946299 Free article.
CD200: a putative therapeutic target in cancer.
Moreaux J, Veyrune JL, Reme T, De Vos J, Klein B. Moreaux J, et al. Biochem Biophys Res Commun. 2008 Feb 1;366(1):117-22. doi: 10.1016/j.bbrc.2007.11.103. Epub 2007 Dec 4. Biochem Biophys Res Commun. 2008. PMID: 18060862
260 results